134 related articles for article (PubMed ID: 25340732)
1. Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data.
Kaur H; Jajodia A; Grover S; Agarwal N; Baghel R; Kukreti R
Pharmacogenomics; 2014; 15(12):1575-87. PubMed ID: 25340732
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
[TBL] [Abstract][Full Text] [Related]
3. The analysis of APOL1 genetic variation and haplotype diversity provided by 1000 Genomes project.
Peng T; Wang L; Li G
BMC Nephrol; 2017 Aug; 18(1):267. PubMed ID: 28800731
[TBL] [Abstract][Full Text] [Related]
4. Interethnic comparisons of important pharmacology genes using SNP databases: potential application to drug regulatory assessments.
Chen J; Teo YY; Toh DS; Sung C
Pharmacogenomics; 2010 Aug; 11(8):1077-94. PubMed ID: 20712526
[TBL] [Abstract][Full Text] [Related]
5. Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.
Li J; Lao X; Zhang C; Tian L; Lu D; Xu S
BMC Genet; 2014 May; 15():52. PubMed ID: 24884825
[TBL] [Abstract][Full Text] [Related]
6. Selected neuropeptide genes show genetic differentiation between Africans and non-Africans.
Tai KY; Wong K; Aghakhanian F; Parhar IS; Dhaliwal J; Ayub Q
BMC Genet; 2020 Mar; 21(1):31. PubMed ID: 32171244
[TBL] [Abstract][Full Text] [Related]
7. Variants of the melanocortin 1 receptor gene (MC1R) and P gene as indicators of the population origin of an individual.
Masui S; Nakatome M; Matoba R
Int J Legal Med; 2009 May; 123(3):205-11. PubMed ID: 18839200
[TBL] [Abstract][Full Text] [Related]
8. Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms.
Bachtiar M; Ooi BNS; Wang J; Jin Y; Tan TW; Chong SS; Lee CGL
Pharmacogenomics J; 2019 Dec; 19(6):516-527. PubMed ID: 31578463
[TBL] [Abstract][Full Text] [Related]
9. A compilation of tri-allelic SNPs from 1000 Genomes and use of the most polymorphic loci for a large-scale human identification panel.
Phillips C; Amigo J; Tillmar AO; Peck MA; de la Puente M; Ruiz-Ramírez J; Bittner F; Idrizbegović Š; Wang Y; Parsons TJ; Lareu MV
Forensic Sci Int Genet; 2020 May; 46():102232. PubMed ID: 31986343
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.
Yang S; Dou X; Wang Z; Zhang W; Ding K; Meng W; Li H; Liu J; Liu Y; Jin T
Mol Genet Genomics; 2022 Mar; 297(2):407-417. PubMed ID: 35146537
[TBL] [Abstract][Full Text] [Related]
11. Efficient selection of tagging single-nucleotide polymorphisms in multiple populations.
Howie BN; Carlson CS; Rieder MJ; Nickerson DA
Hum Genet; 2006 Aug; 120(1):58-68. PubMed ID: 16680432
[TBL] [Abstract][Full Text] [Related]
12. Establishing a second-tier panel of 18 ancestry informative markers to improve ancestry distinctions among Asian populations.
Qu S; Zhu J; Wang Y; Yin L; Lv M; Wang L; Jian H; Tan Y; Zhang R; Liu Y; Li F; Huang S; Liang W; Zhang L
Forensic Sci Int Genet; 2019 Jul; 41():159-167. PubMed ID: 31136932
[TBL] [Abstract][Full Text] [Related]
13. Ayurgenomics for stratified medicine: TRISUTRA consortium initiative across ethnically and geographically diverse Indian populations.
Prasher B; Varma B; Kumar A; Khuntia BK; Pandey R; Narang A; Tiwari P; Kutum R; Guin D; Kukreti R; Dash D; ; Mukerji M
J Ethnopharmacol; 2017 Feb; 197():274-293. PubMed ID: 27457695
[TBL] [Abstract][Full Text] [Related]
14. The limits of genome-wide methods for pharmacogenomic testing.
Gamazon ER; Skol AD; Perera MA
Pharmacogenet Genomics; 2012 Apr; 22(4):261-72. PubMed ID: 22344246
[TBL] [Abstract][Full Text] [Related]
15. Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.
Pimenoff VN; Laval G; Comas D; Palo JU; Gut I; Cann H; Excoffier L; Sajantila A
Pharmacogenet Genomics; 2012 Dec; 22(12):846-57. PubMed ID: 23089684
[TBL] [Abstract][Full Text] [Related]
16. The population genetics of pharmacogenomics VIP variants in the Sherpa population.
Wang L; Ren Y; Shi X; Yuan D; Liu K; Geng T; Li G; Kang L; Jin TB
Drug Metab Pharmacokinet; 2016 Feb; 31(1):82-89. PubMed ID: 26825850
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a transfusion medicine genome wide genotyping array.
Guo Y; Busch MP; Seielstad M; Endres-Dighe S; Westhoff CM; Keating B; Hoppe C; Bordbar A; Custer B; Butterworth AS; Kanias T; Mast AE; Kleinman S; Lu Y; Page GP;
Transfusion; 2019 Jan; 59(1):101-111. PubMed ID: 30456907
[TBL] [Abstract][Full Text] [Related]
18. Validation of genotype imputation in Southeast Asian populations and the effect of single nucleotide polymorphism annotation on imputation outcome.
Lert-Itthiporn W; Suktitipat B; Grove H; Sakuntabhai A; Malasit P; Tangthawornchaikul N; Matsuda F; Suriyaphol P
BMC Med Genet; 2018 Feb; 19(1):23. PubMed ID: 29439659
[TBL] [Abstract][Full Text] [Related]
19. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
Maisano Delser P; Fuselli S
Hum Genet; 2013 May; 132(5):563-77. PubMed ID: 23354977
[TBL] [Abstract][Full Text] [Related]
20. Replication and heritability of prostate cancer risk variants: impact of population-specific factors.
Virlogeux V; Graff RE; Hoffmann TJ; Witte JS
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):938-43. PubMed ID: 25809866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
